Enhancement of amphotericin B activity against Candida albicans by superoxide radical

Mycopathologia

Volumn 158, Issue 1, 2004, Pages 9-15

  Okamoto, Yuichi ^a   Aoki, Shigeji ^a   Mataga, Izumi ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

amphotericin B; Candida albicans; oxidative damage; paraquat; reactive oxygen species

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; PARAQUAT; SUPEROXIDE;

ANIMAL; ARTICLE; CANDIDA ALBICANS; CATTLE; CELL RESPIRATION; CELL SURVIVAL; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MUTAGENESIS; POLAROGRAPHY;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CATTLE; CELL RESPIRATION; CELL SURVIVAL; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS; PARAQUAT; POLAROGRAPHY; SUPEROXIDES;

ANIMALIA; BOS TAURUS; CANDIDA; CANDIDA ALBICANS;

EID: 4444325296     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MYCO.0000038430.20669.80     Document Type: Article

References (13)

1. Aoki S, Ito-Kuwa S. Respiration of Candida albicans in relation to its morphogenesis. Plant Cell Physiol 1982; 23: 721-726.
2. Aoki S, Ito-Kuwa S. Induction of petite mutation with acriflavine and elevated temperature in Candida albicans. J Med Vet Mycol 1987; 25: 269-277.
3. Aoki S, Ito-Kuwa S, Nakamura K, Nakamura Y, Vidotto V, Takeo K. Chemiluminescence of superoxide generated by Candida albicans: Differential effects of the superoxide generator paraquat on a wild-type strain and a respiratory mutant. Med Mycol 2002; 40: 13-19.
4. Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: Current understanding of mechanisms of action. Antimicrob Agents Chemother 1990; 34: 183-188.
5. Hamilton AJ, Holdom MD. Antioxidant systems in the pathogenic fungi of man and their role in virulence. Med Mycol 1999; 37: 375-389.
6. Ito-Kuwa S, Nakamura K, Aoki S, Osafune T, Vidotto V, Pienthaweechai K. Oxidative stress sensitivity and superoxide dismutase of a wild-type parent strain and a respiratory mutant of Candida albicans. Med Mycol 1999; 37: 307-314.
7. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A, Watanabe N. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 2002; 46: 3113-3117.
8. Medoff G. The mechanism of action of amphotericin. In: Van Den Bossche H, Mackenzie DWR, Cauwenbergh G, eds. Aspergillus and Aspergillosis. New York: Plenum Press, 1987: 161-164.
9. Odds FC. Candida and Candidosis. 2nd ed. London: Bailliere Tindall, 1988.
10. Sokol-Anderson ML, Brajtburg J, Medoff G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 1986; 154: 76-83.
11. Sokol-Anderson ML, Brajtburg J, Medoff G. Sensitivity of Candida albicans to amphotericin B administered as single or fractionated doses. Antimicrob Agents Chemother 1986; 29: 701-702.
12. Sokol-Anderson M, Sligh Jr JE, Elaberg S, Brajtburg J, Kobayashi GS, Medoff G. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrob Agents Chemother 1988; 32: 702-705.
13. Wang Y, Casadevall A. Growth of Cryptococcus neoformans in the presence of L-DOPA decreases its susceptibility to amphotericin B. Antimicrob Agents Chemother 1994; 38: 2648-2650.